#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Eosinophilic granulomatosis with polyangiitis Haemophilia B without inhibitors Chondrosarcoma metastatic Solitary fibrous tumour Sarcoidosis Extra-osseous Ewing's sarcoma recurrent Hereditary haemorrhagic telangiectasia Mantle cell lymphoma refractory Still's disease Myelodysplastic syndrome with excess blasts Central nervous system lymphoma Congenital disorder of glycosylation Liposarcoma recurrent Glycogen storage disease type II Cold type haemolytic anaemia More trials…

    Learn about Rare Diseases

    Leiomyosarcoma recurrent – Trials in Disease Hereditary motor and sensory neuropathy Hereditary neuropathic amyloidosis – Basic Information Uterine leiomyosarcoma Skin angiosarcoma Leiomyosarcoma recurrent – Life with Disease Biotinidase deficiency – Treatment Leiomyosarcoma Lymphangiosarcoma – Treatment Isodicentric chromosome 15 syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sabestomig Prednisolone Heparin Tralokinumab Isis 696844 Zamtocabtagene Autoleucel Oditrasertib Riliprubart Asundexian RO7268489 Hyoscine Paeonol Jnj-77242113 Ramucirumab Resomelagon Promazine Hydrochloride Mps-106 Iopromide Mycophenolate Sodium RO7288817 More therapies…

    Learn about Your Condition

    Food allergy Endocarditis enterococcal Acarodermatitis Mitral valve prolapse Hypoalbuminaemia EGFR gene mutation Follicular thyroid cancer Usher's syndrome Cardiogenic shock Colorectal adenoma Cardiac failure congestive Cushing's syndrome Lysosomal storage disorder Breast neoplasm Andersen-Tawil syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on Doravirine and Raltegravir for Maintaining Viral Control in HIV Patients with Low Viral Load

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Doravirine
    • Raltegravir
    France Italy Spain

  • Study on Immune Response in COVID-19 Recovered Patients Treated with Monoclonal Antibodies: Effects of Revaccination with Elasomeran, Tozinameran, and Cilgavimab

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cilgavimab
    • Elasomeran
    • Sars-Cov-2, Spike Protein, Recombinant, Expressed In Sf9 Cells Derived From Spodoptera Frugiperda
    Italy

  • Study on Metformin and Colchicine for Treating Long COVID Symptoms in Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Metformin
    • Colchicine
    The Netherlands

  • Study on Montelukast for COVID-19 Patients at Higher Risk of Complications in the Community

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Montelukast
    The Netherlands

  • Study on Switching to Doravirine and Islatravir for People with HIV-1 on Antiretroviral Therapy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Cobicistat
    • Doravirine
    • Islatravir
    France Italy Spain

  • Study on HIV-1 Treatment for Patients New to Therapy: Comparing Doravirine/Islatravir with a Drug Combination

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Doravirine
    • Islatravir
    • Bictegravir
    France Germany Italy The Netherlands Poland Spain
Previous Page
1 … 20 21 22 23 24 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!